MoonLake Immunothera...
NasdaqCM:MLTX
$ 17,32
$-0,43 (-2,42%)
17,32 $
$-0,43 (-2,42%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,89
Earnings Per Share
$0,00
Revenue Per Share
0,00%
Gross Margin %
$1,24 B
Market Cap
$0,07 B
Long-Term Debt
Earnings Per Share
$-1,89
Revenue Per Share
$0,00
Gross Margin %
0,00%
Market Cap
$1,24 B
Long-Term Debt
$0,07 B

Financials

Year Year 2026 2025 2024 2023 2022
EPS Earnings Per Share $-3,53 $-1,89 $-0,73 $-1,70
Earnings Earnings $-253,21M $-119,60M $-45,90M $-66,56M
RPS Revenue Per Share $0,00 $0,00 $0,00 $0,00 $0,00
Revenue Revenue $0,00M $0,00M $0,00M $0,00M $0,00M
OCF Operating Cash Flow $0,00M $-222,50M $-116,59M $-42,78M $-55,89M
FCF Free Cash Flow $0,00M $-223,00M $-117,11M $-43,06M $-55,91M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 0,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-3,04 $-1,86 $-0,88 $-1,90
LT Debt Long-Term Debt N/A $74,10M N/A N/A N/A
Sha. Stocks 71,73M 71,73M 63,28M 62,87M 39,15M
×